Author: <span>Mesothelioma News</span>

Next generation sequencing in malignant pleural mesothelioma tumors…

Next generation sequencing in malignant pleural mesothelioma tumors shows a complex mutational setting with a high number of genetic alterations in genes involved in DNA repair, cell survival and cell proliferation pathways. Increased accumulation of m…

Family of 66-Year-Old Paper Mill Worker Receives $3.96 Million Asbestos Verdict

December 22, 2014 – A Portland jury has awarded $3.96 million to the family of a 66-year-old Army veteran and former insulation worker who died of malignant mesothelioma in September 2011. Mr. Robert J. Golik was exposed to asbestos while working as an…

Mesothelioma Survivor Makes Video to Change Misconceptions, Raise Awareness of Deadly Cancer

The Mesothelioma Applied Research Foundation was recently featured in a video released by a mesothelioma cancer survivor, Heather Nash, whose goal was to correct misconceptions about this deadly cancer and to request that viewers support the Mesothelio…

Market Report, “Rosetta Genomics, Ltd. (ROSG) – Medical Equipment -…

The company discovers, develops and commercializes next generation diagnostic tests for personalized medicine. It provides testing services such as rosetta cancer origin test, resetta lung cancer test, rosetta kidney cancer test and rosetta mesotheliom…

Crewkerne woman searching for former colleagues of Bowhayes Lodge

A CREWKERNE woman is appealing for people who worked at Bowhayes Lodge between 1995 and 1998 with her to come forward after being diagnosed with an asbestos related disease. Mesothelioma is a cancer of the lining of the lung and is widely linked to asb…

Polaris Group Lead Therapeutic Candidate ADI-PEG 20 Receives Orphan…

Polaris Group announced today that its lead product candidate ADI-PEG 20 has received orphan drug designation for the treatment of malignant pleural mesothelioma in the United States and in the European Union. Orphan drug designation grants special sta…